Ropes Wealth Advisors LLC
- SEC CIK
- 0001641652
- Latest filing
- Oct 19, 2023
NKTR holding history
Nektar Therapeutics in every 13F filed by Ropes Wealth Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
NKTR overviewAll 13F holders of NKTRFull Q3 2023 holdings
- Shares (Q3 2023)
- 11,580
- Value
- $6.90K
- % of portfolio
- <0.1%
- Quarters held
- 11
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2023 | 11,580 | $6.90K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2023 | 11,580 | $6.66K | <0.1% | −5,790−33.3% | Reduced | Holders |
| Q1 2023 | 17,370 | $12.2K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2022 | 17,370 | $39.3K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2022 | 17,370 | $56.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2022 | 17,370 | $66.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2022 | 17,370 | $94.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2021 | 17,370 | $235.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2021 | 17,370 | $312.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2021 | 17,370 | $298.0K | <0.1% | −5,790−25.0% | Reduced | Holders |
| Q1 2021 | 23,160 | $447.0K | 0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.